首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Effects of epigallocatechin gallate on the proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2
【2h】

Effects of epigallocatechin gallate on the proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2

机译:表没食子儿茶素没食子酸酯对鼻咽癌细胞系CNE2增殖和凋亡的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study explored the effects of epigallocatechin gallate (EGCG) on the cell cycle, proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2 in vitro. The proliferation of CNE2 cells was detected using the cell counting kit-8 method. Cell cycle distribution and apoptosis were detected using flow cytometry. The human telomerase reverse transcriptase (hTERT) mRNA expression was determined using reverse transcription polymerase chain reactions. The protein expression of hTERT and Myc proto-oncogene protein (c-Myc) was observed using western blot analysis. EGCG inhibited the proliferation of CNE2 cells in a concentration-dependent manner (P<0.05) and blocked the cell cycle progression of the cells. In the low concentration (100 μg/ml) group, the cell cycle arrest showed a time-dependent manner. However, as the concentration increased and action time was prolonged, this time dependency became less marked. EGCG promoted the apoptosis of CNE2 cells in a time-dependent manner. In addition, EGCG downregulated the mRNA and protein expression of hTERT and downregulated the expression of c-Myc protein. Downregulation of the expression of hTERT and c-Myc was more evident in the high-dose group (200 μg/mL). In conclusion, EGCG has proliferation-inhibiting, cell cycle-blocking and apoptosis-promoting effects on CNE2 cells. EGCG may be developed into an auxiliary therapeutic agent for the treatment of nasopharyngeal carcinoma.
机译:本研究探讨了表没食子儿茶素没食子酸酯(EGCG)对体外培养的鼻咽癌细胞系CNE2细胞周期,增殖和凋亡的影响。使用细胞计数试剂盒8法检测CNE2细胞的增殖。使用流式细胞仪检测细胞周期分布和凋亡。使用逆转录聚合酶链反应确定了人类端粒酶逆转录酶(hTERT)mRNA的表达。使用蛋白质印迹分析观察到hTERT和Myc原癌基因蛋白(c-Myc)的蛋白表达。 EGCG以浓度依赖的方式抑制CNE2细胞的增殖(P <0.05),并阻断细胞的细胞周期进程。在低浓度(100μg/ ml)组中,细胞周期停滞表现出时间依赖性。但是,随着浓度的增加和动作时间的延长,该时间依赖性变得不那么明显。 EGCG以时间依赖性方式促进CNE2细胞的凋亡。此外,EGCG下调hTERT的mRNA和蛋白表达,下调c-Myc蛋白的表达。在高剂量组(200μg/ mL)中,hTERT和c-Myc表达的下调更为明显。总之,EGCG对CNE2细胞具有增殖抑制,细胞周期阻断和凋亡促进作用。 EGCG可以发展成为用于治疗鼻咽癌的辅助治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号